Please use this identifier to cite or link to this item:
Title: Beneficial lactic acid bacteria based bioprocessing of cashew apple juice for targeting antioxidant nutraceutical inhibitors as relevant antidotes to type 2 diabetes
Authors: Ratchadaporn Kaprasob
Dipayan Sarkar
Orapin Kerdchoechuen
Natta Laohakunjit
Chartchai Khanongnuch
Kalidas Shetty
Keywords: Biochemistry, Genetics and Molecular Biology
Chemical Engineering
Immunology and Microbiology
Issue Date: 1-Jul-2019
Abstract: © 2019 Elsevier Ltd Beneficial lactic acid bacteria (LAB)were rationally targeted to bioprocess underutilized byproduct cashew apple juice (CAJ)for enhancing phenolic bioactive-associated antioxidant, anti-hyperglycemic, and anti-hypertensive properties for developing antioxidant nutraceutical antidotes relevant for type 2 diabetes. Lactobacillus plantarum, L. casei and Bifidobacterium longum were used to bioprocess CAJ and then aqueous and 12% ethanol extracts of fermented CAJ were analyzed for total soluble phenolic (TSP)content, phenolic acid profile (HPLC), total antioxidant activity, type 2 diabetes relevant α-glucosidase, and α-amylase enzyme inhibitory activities and hypertension relevant angiotensin-I-converting (ACE)enzyme inhibitory activity using in vitro assay models. Overall, high TSP content, moderate to high antioxidant activity, moderate ACE inhibitory activity and high α-glucosidase and α-amylase enzyme inhibitory activity was observed in bioprocessed CAJ. Therefore, this study suggests that bioprocessing of CAJ from cashew byproducts with L. plantarum and L. casei is an effective strategy for obtaining type 2 diabetes relevant antioxidant nutraceuticals.
ISSN: 13595113
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.